PharmaEssentia Initiates Phase 3b Trial of Ropeginterferon alfa-2b-njft Investigatng New Dosing Regimen for Patients With Polycythemia Vera (PV)

Press/Media

Period	3 May 2023

Media coverage

Title	PharmaEssentia Initiates Phase 3b Trial of Ropeginterferon alfa-2b-njft Investigatng New Dosing Regimen for Patients With Polycythemia Vera (PV)
Media name/outlet	South Africa - Knowledia News
Country/Territory	South Africa
Date	3/05/23
URL	ct.moreover.com/?a=50679056365&p=1gw&v=1&x=_Bg4LJ03CJBzIhYvaJDGmA
Persons	John Mascarenhas